SpringWorks Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Conference
SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases ...
ETF Daily News1d
Massachusetts Financial Services Co. MA Acquires 108,109 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)
Massachusetts Financial Services Co. MA lifted its holdings in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Free Report) by 20.2% during the 3rd quarter, Holdings Channel reports. The firm ...
Vertex leads J.P. Morgan's top biotech picks list for 2025
J.P. Morgan said its top biotech picks for 2025 were Vertex, Travere, SpringWorks, PTC Therapeutics, Wave Life Sciences, ...
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Shares Sold by Mutual of America Capital Management LLC
Mutual of America Capital Management LLC trimmed its position in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Free ...
SpringWorks Therapeutics Inc. (SWTX): Among the NASDAQ Stocks with Biggest Upside Potential According to Analysts
We recently compiled a list of the 12 NASDAQ Stocks with Biggest Upside Potential According to Analysts. In this article, we ...
SpringWorks Therapeutics to Participate in the Jefferies London Healthcare Conference
SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases ...
SpringWorks Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
Achieved $49.3 million in OGSIVEO® (nirogacestat) net product revenue in the third quarter – – Long-term follow-up data from ...
J.P. Morgan Sticks to Their Buy Rating for Springworks Therapeutics (SWTX)
In a report released on November 19, Anupam Rama from J.P. Morgan maintained a Buy rating on Springworks Therapeutics (SWTX – Research Report), ...
12 NASDAQ Stocks with Biggest Upside Potential According to Analysts
In this article, we’re going to talk about the 12 NASDAQ stocks with biggest upside potential according to analysts. Potomac ...
Fintel on MSN6d
Evercore ISI Group Initiates Coverage of SpringWorks Therapeutics (SWTX) with Outperform Recommendation
Fintel reports that on November 20, 2024, Evercore ISI Group initiated coverage of SpringWorks Therapeutics (NasdaqGS:SWTX) ...
Springworks Therapeutics (SWTX) Gets a Buy from Evercore ISI
Springworks Therapeutics (SWTX – Research Report) received a Buy rating and a $60.00 price target from Evercore ISI analyst Cory Kasimov today.